Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what information his Department holds on whether there is a casual link between the Oxford AstraZeneca covid-19 vaccine and incidences of blood clots.

On 18 March 2021, the Medicines and Healthcare products Regulatory Agency, the United Kingdom regulator responsible for investigating medicines safety concerns, issued a statement setting out that the available evidence did not suggest that blood clots in veins are caused by the Oxford/AstraZeneca COVID-19 vaccine. This followed a rigorous scientific review of all the available data, including a detailed review of report cases as well as data from hospital admissions and general practitioner records. This has been confirmed by the Government’s independent advisory group, the Commission on Human Medicines, whose expert scientists and clinicians have also reviewed the available data.